Switzerland Gaelle Meaude, operations director of Thea Switzerland, talks about building an effective sales and marketing team over the last few years; why the Swiss preservative-free eye care market remains particularly dynamic; and how working for a French family run entrepreneurial company, with five generations of expertise in the field of…
Switzerland Nicolas Hug reveals how UCB´s new facility in Bulle, Switzerland, is one of the largest microbial derived pharmaceuticals plants in Europe; how the key challenge for manufacturers today is to guarantee supplies by building a robust network; and why manufacturing is where dreams become reality, taking the results from a…
Luxembourg Luxembourg has a young and ambitious life sciences community, which has identified four aspects of personalized medicine where the country has significant potential: digital health, neurodegenerative diseases, molecular diagnostics and immune-oncology. Thomas Dentzer, Head of the Life Sciences sector in Luxembourg, discusses the flexible and supportive atmosphere for companies and…
Luxembourg Jean-Paul Schuler, CEO of Luxinnovation – Luxembourg’s National Agency for Innovation and Research –, explains how his team is working hard to contribute to Luxembourg’s economic development by fostering innovation, fueling international growth and attracting foreign direct investment. He also explains why Luxembourg is an excellent place for companies looking to…
Singapore CEO of the Asia Pacific Medical Technology Association (APACMed), Fredrik Nyberg explains the rationale behind the creation of the first regional medical technology association; the industry challenges ahead, and the critical importance of bringing together all industry stakeholders to effectively advance the development of medical technology across Asia Pacific. …
Switzerland As the home market, Switzerland and Roche’s Swiss pharma operations play an important and pioneering role within Roche’s global organization, with early patient access to innovation and new commercial models taking place in the country. The working title of the Healthcare & Life Science Review Switzerland is “A Leader Among…
Philippines Stephanie Franco, Managing Director of Fresenius Medical Care in the Philippines, emphasizes the strategic importance of the Asia-pacific region to Fresenius Medical Care’s future growth and outlines her goals for the company and its role within both the renal space and the Filipino healthcare ecosystem. We have seen an increased…
Czech Republic One of the very first former-communist European states to attain a successful economic transition, the Czech Republic today puts across a compelling argument for being regarded as one of the regional leaders in pharmaceuticals, healthcare and life sciences. In the Czech Republic we have the right balance between sophisticated…
Czech Republic Entrepreneurially-minded individuals, together with academic institutions with their fingers on the pulses of the latest trends, are propelling Czech pharma companies to great success and cementing the Czech Republic at the forefront of healthcare innovation in Central Europe. [Czech know-how should not] be compared with the stereotype of Eastern…
Pfizer Rodrigo Puga, the recently appointed general manager of Pfizer Mexico, documents his strategic priorities to further strengthen the company’s performance in Mexico and consolidate Pfizer’s leadership within the Mexican market and the overall healthcare eco-system of the country. You were appointed country manager of Pfizer Mexico in June 2016, while…
Switzerland Heike Behn, reveals how her number one priority at Nordic Pharma Switzerland, the group’s’newest affiliate, is to develop their rheumatology business, building on their gynecology platform; how the speed with which they can approach the customer is a major competitive advantage for the company; and how Switzerland´s approval process, when…
Mexico General Manager of Merck Mexico, Pedro Galvis, showcases the strategic importance of the Mexican affiliate within Merck’s global network and explains the importance of public-private partnerships in enhancing patient access and treatment in emerging markets. “The Mexican affiliate is a strong contributor to the region’s revenues and one of…
See our Cookie Privacy Policy Here